Chc Healthcare Group · TWSE:4164

Chc Healthcare — 2015 Institutional Investor Conference

23 slides from Chc Healthcare's conference presentation, Dec 19, 2015

  1. Slide 1: CHC Healthcare Group 2015 Institutional Investor Conference

    CHC Healthcare Group (4164 TT) 2015 Institutional Investor Conference 1

  2. Slide 2: Disclaimer

    Disclaimer • The information contained in this confidential document ("Presentation") has been prepared by CHC Health Care Group (the "Company"). It has not been fully verified and is subject to material updating, revision and further amendment. • While the information contained herein has been prep

  3. Slide 3: Agenda: Company Overview, Financial Results, Guidance

    Company Overview Financial Q&A Results Guidance in the Future

  4. Slide 4: Company Overview

    Company Overview Financial Q&A Results Guidance in the Future

  5. Slide 5: Company Introduction

    Company Introduction • Name : CHC Healthcare Group (4164 TT) • Date of Establish : 2009/11/27 (the first subsidiary-Chiu Ho Medical was founded on 1977/08/12) • Chairman : Mr. Lee Pei-Lin • Headquarters : Taipei • Branches : Taichung and Kaohsiung • Subsidiary : Beijing and Guangzhou • Paid-in Capit

  6. Slide 6: Company Milestones

    Company Milestones 2015 2013 2011 •Exclsive Distributor •Cooperation for IBA Proton with Lippo •Set up Guangzhou Therapy System •Acquired ChiuHo Co. 2006 •Exclsive Distributor SHIH-LU •Listed in Taiwan for GE Nuclear •Established Gretai market as Medicine & 1999 Ophthalmology Emerging Stock Diagnost

  7. Slide 7: Exclusive Distributor for Top Global Brands

    Exclusive Distributor for Top Global Brands Radiotherapy and Nuclear Medicine & Ophthalmology Neurology Diagnostic Imaging

  8. Slide 8: Value-Added Business Model

    Value-Added Business Model Direct Selling Maintenance Revenue Sharing

  9. Slide 9: Full Service Solution Provider

    Full Service Solution Provider “TurnKey Solutions” Manufacturer Site Planning Products: • Radiation Oncology Site Construction • Neuroscience CHC • Ophthalmology Operational Healthcare Group Consulting • Medical Imaging • Surgery Installation Revenue Distribution Services Sharing Partnerships Educat

  10. Slide 10: Manufacturers Certified Service Team

    Manufacturers Certified Service Team CHC’s experienced consulting and service team is a critical factor in our success. Manufacturers rely on CHC to provide this operational support and after-sales service. CHC’s 30 years of investment in establishing, training and re-certifying our service team is

  11. Slide 11: Financial Results

    Company Overview Q&A Financial Results Guidance in the Future

  12. Slide 12: Financial Comparison: Sales by Month YOY

    Financial Comparison Sales by Month—YOY (NT$ thousand) 400,000 350,000 300,000 250,000 200,000 2014 2015 150,000 100,000 50,000 0 Jan Feb Mar Apr May Jun Jul Aug Sep Oct Nov 2014 2015 YOY 2014 2015 YOY Jan 96,021 98,052 2.12% Jul 117,459 122,525 4.31% Feb 116,635 91,595 -21.47% Aug 104,198 117,614 1

  13. Slide 13: Financial Comparison 2015Q3 vs 2014Q3

    Financial Comparison 2015Q3 VS 2014Q3 (NT$ thousand) 700,000 600,000 500,000 400,000 2014 Q3 300,000 2015 Q3 200,000 100,000 0 Sales Gross Profit OP Profit Net Profit Profit (parent) 2014 Q3 2015 Q3 YOY Sales 410,647 598,054 45.64% Gross Profit 134,308 197,913 47.36% Gross Margin(%) 33% 33% 0% OP Pr

  14. Slide 14: Financial Highlights

    Financial Highlights Revenue Gross Profit & Gross Margin (NT$ thousand) (NT$ thousand) 1,400,000 46.3% 50.0% 2,500,000 41.7% 41.4% 45.0% 1,200,000 40.0% 2,200,000 2,062,991 2,091,026 1,000,000 923,272 31.0% 35.0% 1,995,368 1,989,670 29.0% 778,153 824,514 30.0% 1,867,510 800,000 1,900,000 638,949 606

  15. Slide 15: Guidance in the Future

    Company Overview Financial Q&A Results Guidance in the Future

  16. Slide 16: Global Views: Radiotherapy Unit Penetration

    Global Views Penetration Rates of Radiotherapy Units by Region (2013) (Unit / Million Inhabitants) 12.37 8.28 8.07 7.51 7.22 7.17 6.90 6.44 6.41 6.21 5.04 4.77 3.51 3.00 2.28 1.41 1.10 0.97 0.57 0.54 0.41 0.22 0.18 0.15 0.12 0.08 0.06

  17. Slide 17: Strategy in China

    Strategy in China Radiation Oncology Neuroscience Medical Imaging The First People‘s Hospital of Chenzhou China

  18. Slide 18: Cooperation with Lippo

    Cooperation with Lippo SiloamSHospitals A oy = 5 a i a | | | Bee LIPPO GROUP REL CHC HEALTHCARE GROUP

  19. Slide 19: IBA Proton Therapy

    \ \ PENCIL BEAM SCANNING BY IBA ALLOWS INTENSITY MODULATED PROTON THERAPY

  20. Slide 20: Products and Geography Expansion

    Products and Geography Expansion Cancer Center Consulting & Management (Taiwan、China、Indonesia、Myanmar) IBA Proton Therapy Swissray Radiological Imaging Equipment (Greater China) Product Pipeline Novadaq SPY Fluorescence Imaging Technology (Greater China) White Essence Dental Clinic (Exclusive Great

  21. Slide 21: Be the Leading Medical Equipment Full Service Solutions Provider in Asia-Pacific

    Be the Leading Medical Equipment Full Service Solutions Provider in Asia-Pacific Subsidiary in Beijing Headquarter in Taiwan Subsidiary in Myanmar Guangzhou Indonesia

  22. Slide 22: Q & A

    Company Overview Q&A Financial Results Guidance in the Future

  23. Slide 23: Thank you

    EY *EES CHC HEALTHCARE GROUP

CHC Healthcare Group — 2015 Institutional Investor Conference on 6ix